Heritable collagen disorders: From genotype to phenotype

Acta Clinica Belgica

Volumn 56, Issue 1, 2001, Pages 10-16

  De Paepe, A ^a   Nuytinck, L ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Collagen; Ehlers Danlos Syndrome; Mutations; Osteogenesis Imperfecta

Indexed keywords

COLLAGEN;

ARTICLE; COLLAGEN DISEASE; CONNECTIVE TISSUE; EHLERS DANLOS SYNDROME; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENOTYPE; HUMAN; OSTEOGENESIS IMPERFECTA; PHENOTYPE;

EID: 0035085755     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2001.003     Document Type: Article

References (45)

1. International nosology of heritable disorders of connective tissue, Berlin, 1986
2. Molecular nosology of heritable disorders of connective tissue
3. Mutations in fibrillar collagens (types I, II, III, and XI), fibril-associated collagen (type IX), and network-forming collagen (type X) cause a spectrum of disease of bone, cartilage, and blood vessels
4. Type VI collagen mutations in Bethlem myopathy, an autosomal dominant myopathy with contractures
5. Collagen family of proteins
6. Collagen: The collagen family: Structure, assembly and organization in the extracellular matrix
7. The collagen superfamily
8. Collagen fibrillogenesis in vitro: Interaction of types I and V collagen regulates fibril diameter
9. Collagen genes: Mutations affecting collagen structure and expression
10. Molecular basis of hereditary disorders of connective tissue
11. Collagen: Gene structure
12. Genetic heterogeneity in osteogenesis imperfecta
13. Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneity
14. Osteogenesis Imperfecta
15. Premature chain termination is an unifying mechanism for COL1A1 null alleles in osteogenesis impeffecta type I cell strains
16. Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type I: Identification of common sequences of null-allele mutations
17. Perinatal lethal osteogenesis imperfecta (OI type II): A biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen
18. Collagens: Building blocks at the end of the development line
19. Substitution of glycine-661 by serine in the α1(I) and α2(I) chains of type I collagen results in different clinical and biochemical phenotypes
20. Mutation in a gene for type I procollagen (COL1A2) in a woman with postmenopausal osteoporosis: Evidence for phenotypic and genotypic overlap with mild osteogenesis imperfecta
21. OI phenotypes resulting from serine for glycine substitutions in the a2(I) collagen chain
22. Recurrence of lethal osteogenesis imperfecta due to parental mosaïcism for a dominant mutation in a human type I collagen gene (COL1A1)
23. Homozygosity by descent for a COL1A2 mutation in two sibs with severe osteogenesis imperfecta and mild clinical expression in the heterozygotes
24. Strategies and outcomes of prenatal diagnosis for osteogenesis imperfecta: Review of biochemical and molecular studies completed in 129 pregnancies
25. A 4 bp insertion polymorphism in the 3′ UTR of the COL1A1 gene is highly informative for null-allele testing in patients with OI type I
26. The clinical features of Ehlers-Danlos syndrome type VII due to a deletion of 24 amino acids from the pro-al (I) chain of type I procollagen
27. Ehlers-Danlos syndrome type VIIA and VIIB result from splice-junction mutations or genomic deletions that involve exon 6 in the COL1A1 and COL1A2 genes of type I collagen
28. Evidence for a relationship between Ehlers-Danlos type VII(C) in humans and bovine dermatosparaxis
29. Human dermatosparaxis: A form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen
30. Ehlers-Danlos syndromes: Revised nosology, Villefranche 1997
31. Patients with Ehlers-Danlos syndrome type IV lack type III collagen
32. Linkage of a polymorphic marker for the type III collagen gene (COL3A1) to aptypical autosomal dominant Ehlers-Danlos syndrome type IV in a large Belgian pedigree
33. The Ehlers-Danlos syndrome
34. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type
35. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development
36. Ehlers-Danlos syndrome type IV: Clinical and molecular aspects and guidelines for diagnosis and management
37. Linkage of the gene that encodes the a1 chain of type V collagen (COL5A1) to type II Ehlers-Danlos syndrome (EDS II)
38. Targeted mutation in the COL5A2 gene reveals a regulatory role for type V collagen during matrix assembly
39. 2-terminal domain, a putative regulator of corneal fibrillogenesis
40. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II
41. Mutations of the α2(V) chain of type V collagen impair matrix assembly and produce Ehlers-Danlos syndrome type I
42. A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families
43. Null alleles of the COL5A1 gene of type V collagen are a cause of the classical form of Ehlers-Danlos syndrome (types I and II)
44. COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS
45. Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen